PROMISEMED
DEAD

Serial Number

79283093

Owner

Promisemed Hangzhou Meditech Co.,Ltd.

Filing Date

Dec 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PROMISEMED Trademark

Serial Number: 79283093

PROMISEMED is a trademark filed by Promisemed Hangzhou Meditech Co.,Ltd. on December 17, 2019. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Promisemed Hangzhou Meditech Co.,Ltd. (4 trademarks)

Building 1, No.12, Longtan Road
Zhejiang Province , CN

Entity Type: 16

Trademark Details

Filing Date

December 17, 2019

Registration Date

Not Registered

Goods & Services

Syringes for medical purposes; dialyzers; medical guidewires; medical apparatus and instruments for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events; thermal packs for first aid purposes; catheters; surgical implants comprised of artificial materials; teething rings; condoms

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 12, 2021 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 23, 2021 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2021 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 15, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 15, 2021 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 23, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 23, 2020 ABN2
REFUSAL PROCESSED BY IB
May 23, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 4, 2020 RFCS
REFUSAL PROCESSED BY MPU
May 4, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 24, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 23, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 22, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 14, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 9, 2020 REPR